PH-027

N/A

Report date: 2024/05/08 17:40:12
NME

Base Information

Drug NamePH-027
Drug Alias NamePH-027PH027
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsMismatch Repair Deficient Cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Puhe Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Puhe Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMismatch Repair Deficient Cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A